Related Experiment Video
Updated: Aug 6, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal
Junichi Ishigami1, Mayank Kansal2, Rupal Mehta3
1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
Insights
Cardiac abnormalities increase the risk of kidney failure in chronic kidney disease (CKD) patients. Echocardiographic measures of heart structure and function are linked to kidney disease progression and kidney replacement therapy.
Area of Science:
- Cardiology
- Nephrology
- Cardiorenal Medicine
Background:
- Cardiorenal syndrome highlights the intricate relationship between heart and kidney health.
- Understanding the impact of cardiac function on chronic kidney disease (CKD) progression is crucial.
Purpose of the Study:
- To investigate the association between cardiac structure and function with the risk of kidney failure requiring replacement therapy (KFRT) in a CKD population.
- To determine if echocardiographic parameters predict the rate of estimated glomerular filtration rate (eGFR) decline.
Main Methods:
- A prospective observational cohort study involving 3,027 participants from the Chronic Renal Insufficiency Cohort Study.
- Echocardiography was used to assess left ventricular mass index (LVMI), LV volume, left atrial (LA) area, peak tricuspid regurgitation (TR) velocity, and left ventricular ejection fraction (EF).
- Multivariable Cox and mixed-effects models were employed to analyze the association with KFRT and eGFR slope.
Main Results:
- Higher LVMI, LV volume, LA area, and peak TR velocity, along with lower EF, were significantly associated with an increased risk of KFRT.
- The highest versus lowest quartiles showed hazard ratios for KFRT ranging from 1.26 (for EF) to 1.70 (for LVMI).
- Faster eGFR decline was observed in participants with higher LVMI, LV volume, and peak TR velocity, and lower EF, compared to those with the lowest values.
Conclusions:
- Multiple echocardiographic measures of cardiac structure and function are significantly associated with an elevated risk of kidney failure in CKD patients.
- These findings suggest a shared pathway involving hypertension, heart failure, and coronary artery disease in cardiorenal syndrome.
- Abnormal cardiac structure and function may play a key role in the progression of kidney disease.
Rationale & Objective:
Heart-kidney crosstalk is recognized as the cardiorenal syndrome. We examined the association of cardiac function and structure with the risk of kidney failure with replacement therapy (KFRT) in a chronic kidney disease (CKD) population.
Study Design:
Prospective observational cohort study.
Setting & Participants:
3,027 participants from the Chronic Renal Insufficiency Cohort Study.
Exposure:
Five preselected variables that assess different aspects of cardiac structure and function: left ventricular mass index (LVMI), LV volume, left atrial (LA) area, peak tricuspid regurgitation (TR) velocity, and left ventricular ejection fraction (EF) as assessed by echocardiography.
Outcome:
Incident KFRT (primary outcome), and annual estimated glomerular filtration rate (eGFR) slope (secondary outcome).
Analytical Approach:
Multivariable Cox models and mixed-effects models.
Results:
The mean age of the participants was 59±11 SD years, 54% were men, and mean eGFR was 43±17mL/min/1.73m2. Between 2003 and 2018 (median follow-up, 9.9 years), 883 participants developed KFRT. Higher LVMI, LV volume, LA area, peak TR velocity, and lower EF were each statistically significantly associated with an increased risk of KFRT, with corresponding HRs for the highest versus lowest quartiles (lowest vs highest for EF) of 1.70 (95% CI, 1.27-2.26), 1.50 (95% CI, 1.19-1.90), 1.43 (95% CI, 1.11-1.84), 1.45 (95% CI, 1.06-1.96), and 1.26 (95% CI, 1.03-1.56), respectively. For the secondary outcome, participants in the highest versus lowest quartiles (lowest vs highest for EF) had a statistically significantly faster eGFR decline, except for LA area (ΔeGFR slope per year, -0.57 [95% CI, -0.68 to-0.46] mL/min/1.73m2 for LVMI, -0.25 [95% CI, -0.35 to-0.15] mL/min/1.73m2 for LV volume, -0.01 [95% CI, -0.12 to-0.01] mL/min/1.73m2 for LA area, -0.42 [95% CI, -0.56 to-0.28] mL/min/1.73m2 for peak TR velocity, and -0.11 [95% CI, -0.20 to-0.01] mL/min/1.73m2 for EF, respectively).
Limitations:
The possibility of residual confounding.
Conclusions:
Multiple aspects of cardiac structure and function were statistically significantly associated with the risk of KFRT. These findings suggest that cardiac abnormalities and incidence of KFRT are potentially on the same causal pathway related to the interaction between hypertension, heart failure, and coronary artery diseases.
Plain-Language Summary:
Heart disease and kidney disease are known to interact with each other. In this study, we examined whether cardiac abnormalities, as assessed by echocardiography, were linked to the subsequent progression of kidney disease among people living with chronic kidney disease (CKD). We found that people with abnormalities in heart structure and function had a greater risk of progression to advanced CKD that required kidney replacement therapy and had a faster rate of decline in kidney function. Our study indicates the potential role of abnormal heart structure and function in the progression of kidney disease among people living with CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention

